Medicus Pharma Ltd opened higher at $1.68, compared with its previous close of $1.64. In the last trading session, the stock traded between $1.65 and $1.74. It showed an upward intraday trend.
Return calculator
Time Period
An investment of $100 made 2 years ago in Medicus Pharma Ltd is now worth
$ 62.57
Resulting in a loss of
$ 37.43 (37.43%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 4 Analysts
Buy
75%
Hold
25%
Sell
0%
Markets Today
Today's Change
+$0.02 (+1.10%)
Day High
$1.74
Day Low
$1.65
Day Open
$1.68
Prev Close
$1.64
Volume
36,278
1W Return
-9.79%
1M Return
-54.51%
3M Return
372.36%
6M Return
398.50%
1Y Return
-26.31%
Fundamentals
Market Cap ($ Mn)
3
PE Ratio
-
PB Ratio
-
PEG Ratio
-
ROE
-2,346.29%
ROCE
-2,074.29%
EPS (TTM)
$-7.51
Investment Returns
1 Week
-9.79%
1 Month
-54.51%
3 Months
372.36%
6 Months
398.50%
9 Months
74.53%
Financials
Quarterly
All values in $ Mn
0.0
Dec 24
0.0
Mar 25
0.0
Jun 25
0.0
Sep 25
0.0
Dec 25
0.0
Mar 26
Updates
9Nov
Medicus Pharma Q3FY26 Results: Net loss narrows to $15.2 million
Net loss narrowed to $15.2 million in Q3FY26 from $16.0 million in Q3FY25. Company raised $42.5 million through equity and debt financing in 9MFY26. Nine-month net loss widened to $35.9 million due to $10 million IPR&D charge. SkinJect SPAC merger targeted for first half of 2027 at $135 million valuation.
3 days ago
9Nov
Medicus Pharma unveils capital strategy centered on cancer pipeline
Medicus Pharma prioritizes precision oncology via Pfizer-licensed CD228V asset. Proposed SPAC deal values dermatology subsidiary SkinJect at $135 million. Net cash generated from financing was $36.2 million in first nine months of 2026. Company anticipates operating expense reductions while seeking partners for Teverelix.
3 days ago
26Oct
Medicus Pharma regains compliance with Nasdaq minimum bid price rule
Regained compliance with Nasdaq's $1.00 minimum bid price requirement. Shares closed at or above $1.00 for ten consecutive business days. Notice received from Nasdaq Listing Qualifications Department on October 23, 2026. Company remains subject to other continued listing requirements.
